4 days ago
KYTX
AnalystsMichael UlzMichael Ulz's Stock Forecasts
AnalystsMichael Ulz
Sectors:
Industries:
Analyst Ranking
Top 9%
#442 out of 5134 analysts
Average Return
+21.19%
Win Rate
54%45 out of 84
Risk vs Reward
Poor
Good
Michael Ulz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Silence Therapeutics PLCSLN | +310.96% | $5.29 | $21.74 | 2023-07-24 - 2024-07-23 | Strong Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Strong Buy |
Kyverna Therapeutics IncKYTX | +293.94% | $1.98 | $7.80 | 2025-04-01 - 2025-12-05 | Strong Buy |
Silence Therapeutics PLCSLN | +261.98% | $5.76 | $20.85 | 2023-06-12 - 2024-06-11 | Strong Buy |
Iveric Bio IncISEE | +255.14% | $11.19 | $39.74 | 2022-07-07 - 2023-07-06 | Strong Buy |
Michael Ulz Analyst Color
Get additional color on Michael Ulz's coverage of popular stocks
a month ago
IONS
a month ago
VKTX
2 months ago
MIRM
2 months ago
IONS
2 months ago
IONS
10 months ago
AKRO
a year ago
DYN
a year ago
THRD
a year ago
SLN
a year ago
MIRM
2 years ago
ALPN
Michael Ulz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kyverna Therapeutics IncKYTX | 3 | Strong Buy | $25.00 | +220.51% | Maintains | 4 days ago |
Arrowhead Pharmaceuticals IncARWR | 6 | Hold | $48.00 | -21.88% | Maintains | 12 days ago |
Ionis Pharmaceuticals IncIONS | 8 | Strong Buy | $94.00 | +15.08% | Maintains | a month ago |
Viking Therapeutics IncVKTX | 4 | Strong Buy | $102.00 | +164.59% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 4 | Strong Buy | $81.00 | +18.28% | Maintains | 2 months ago |
Karyopharm Therapeutics IncKPTI | 8 | Buy | $21.00 | +265.22% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 12 | Hold | $475.00 | +3.68% | Maintains | 2 months ago |
Silence Therapeutics PLCSLN | 12 | Strong Buy | $25.00 | +259.20% | Maintains | 7 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $22.00 | +762.75% | Maintains | 8 months ago |
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $29.00 | +113.86% | Initiates Coverage On | 9 months ago |
Y Mabs Therapeutics IncYMAB | 6 | Strong Sell | $7.00 | -18.70% | Maintains | 9 months ago |
Iovance Biotherapeutics IncIOVA | 4 | Buy | $20.00 | +809.09% | Maintains | 9 months ago |
Third Harmonic Bio IncTHRD | 5 | Hold | $5.00 | -7.06% | Downgrades | 10 months ago |
Fractyl Health IncGUTS | 2 | Strong Buy | $10.00 | +390.20% | Maintains | 10 months ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $96.00 | +75.99% | Maintains | 10 months ago |
Dyne Therapeutics IncDYN | 2 | Strong Buy | $52.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $115.00 | N/A | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fate Therapeutics IncFATE | 7 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Kalaris Therapeutics IncKLRS | 4 | Strong Sell | $11.50 | N/A | Downgrades | 2 years ago |
Oric Pharmaceuticals IncORIC | 2 | Buy | $27.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 8 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Iveric Bio IncISEE | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Senti Biosciences IncSNTI | 3 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Xilio Therapeutics IncXLO | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Allakos IncALLK | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Taysha Gene Therapies IncTSHA | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Vir Biotechnology IncVIR | 1 | Hold | $30.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Jounce Therapeutics IncJNCE | 3 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Tectonic Therapeutic IncTECX | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $38.00 | N/A | Downgrades | 4 years ago |
Iteos Therapeutics IncITOS | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Neurogene IncNGNE | 1 | Buy | $125.00 | N/A | Initiates Coverage On | 5 years ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $500.00 | N/A | Maintains | 6 years ago |
Atreca IncBCEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Merrimack Pharmaceuticals IncMACK | 2 | Hold | $4.00 | N/A | Maintains | 7 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Maintains | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $80.00 | N/A | Maintains | 8 years ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $15.00 | N/A | Maintains | 8 years ago |
Tesaro IncTSRO | 1 | Hold | $182.00 | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.